Live from the NIH registry
Studies recruiting near Paterson right now
Top 25 of 4,154 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Weill Cornell Medicine (Adults only) — New York, New York (16.1 mi)
· Sponsor: Pierre Fabre Medicament
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — New Hyde Park, New York (27.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Prematurity
N/A
Interventional 120 participants sought
Mount Sinai Hospitals — New York, New York (16.1 mi)
· Sponsor: Icahn School of Medicine at Mount Sinai
FUS Etoposide for DMG
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Phase 1
Interventional 10 participants sought
Columbia University Irving Medical Center — New York, New York (16.1 mi)
· Sponsor: Columbia University
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
NYU Langone — New York, New York (16.1 mi)
· Sponsor: Revolution Medicines, Inc.
DBS for Depression
Treatment Resistant Depression
Phase 1
Interventional 20 participants sought
Zucker Hillside Hospital — Queens, New York (23.5 mi)
· Sponsor: Northwell Health
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Joseph's Regional Medical Center — Paterson, New Jersey (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Integrated Medical Professionals — New York, New York (16.1 mi)
· Sponsor: Pacific Edge Limited
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Hearing Impairment
N/A
Interventional 13 participants sought
NYU Langone Health — New York, New York (16.1 mi)
· Sponsor: NYU Langone Health
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Harlem Prevention Center — New York, New York (16.1 mi)
· Sponsor: Westat
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
Sloan Kettering Institute for Cancer Research — New York, New York (16.1 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Adams Clinical Bronx — The Bronx, New York (16.1 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
NYC Research Inc — Long Island City, New York (16.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Hospital for Special Surgery — New York, New York (16.1 mi)
· Sponsor: University of Pennsylvania
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
New York Medical College — Valhalla, New York (23.0 mi)
· Sponsor: New York Medical College
Mobile CBT for Middle Aged and Older Adults
Anxiety Disorders and Symptoms, Depressive Symptoms
N/A
Interventional 60 participants sought
Weill Cornell Medicine — New York, New York (16.1 mi)
· Sponsor: Weill Medical College of Cornell University
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Cigarette Smoking
N/A
Interventional 60 participants sought
NYU Langone Health — New York, New York (16.1 mi)
· Sponsor: NYU Langone Health
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (16.1 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
Mild Cognitive Impairment (MCI), Cognitive Training
Phase 2
Interventional 240 participants sought
Columbia University Irving Medical Center — New York, New York (16.1 mi)
· Sponsor: Columbia University
Pain Reprocessing Therapy in Post-Operative Knee Pain
Pain, Chronic, Knee Pain Chronic
Phase 2
Interventional 110 participants sought
Hospital for Special Surgery — New York, New York (16.1 mi)
· Sponsor: Weill Medical College of Cornell University
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Columbia University Cystic Fibrosis Program — New York, New York (16.1 mi)
· Sponsor: Jaeb Center for Health Research
Universal Genetic Testing for Cancer Risk Reduction
Genetic Testing
N/A
Interventional 600 participants sought
NYU Langone Health — New York, New York (16.1 mi)
· Sponsor: NYU Langone Health
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in New York, NY — New York, New York (16.1 mi)
· Sponsor: Mediar Therapeutics
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
Age-related Macular Degeneration (AMD)
N/A
Observational 1,076 participants sought
iHealthScreen Inc. — Richmond Hill, New York (22.8 mi)
· Sponsor: iHealthScreen Inc
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (16.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center